Why the Psychosomatic View on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Inconsistent with Current Evidence and Harmful to Patients

Overview

Journal Medicina (Kaunas)

Publisher MDPI

Specialty General Medicine

Date 2024 Jan 23

PMID 38256344

Authors

Manuel Thoma

Laura Froehlich

Daniel B R Hattesohl

Sonja Quante

Leonard A Jason

Carmen Scheibenbogen

Affiliations

Soon will be listed here.

Abstract

Since 1969, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) has been classified as a neurological disease in the International Classification of Diseases by the World Health Organization. Although numerous studies over time have uncovered organic abnormalities in patients with ME/CFS, and the majority of researchers to date classify the disease as organic, many physicians still believe that ME/CFS is a psychosomatic illness. In this article, we show how detrimental this belief is to the care and well-being of affected patients and, as a consequence, how important the education of physicians and the public is to stop misdiagnosis, mistreatment, and stigmatization on the grounds of incorrect psychosomatic attributions about the etiology and clinical course of ME/CFS.

Citing Articles

mTORC1 syndrome (TorS): unifying paradigm for PASC, ME/CFS and PAIS.

Bar-Tana J J Transl Med. 2025; 23(1):297.

PMID: 40059164 PMC: 11892318. DOI: 10.1186/s12967-025-06220-z.

CBT and graded exercise therapy studies have proven that ME/CFS and long COVID are physical diseases, yet no one is aware of that.

Vink M, Vink-Niese A Front Hum Neurosci. 2025; 19:1495050.

PMID: 39944089 PMC: 11814198. DOI: 10.3389/fnhum.2025.1495050.

I'm Not the Doctor for You: Cognitive Bias, Complex Illness, and a Moral Imperative.

Kuon C Glob Adv Integr Med Health. 2025; 14():27536130241311594.

PMID: 39790367 PMC: 11713959. DOI: 10.1177/27536130241311594.

The Post-Acute COVID-19-Vaccination Syndrome in the Light of Pharmacovigilance.

Platschek B, Boege F Vaccines (Basel). 2025; 12(12.

PMID: 39772040 PMC: 11680367. DOI: 10.3390/vaccines12121378.

[Interdisciplinary, collaborative D-A-CH (Germany, Austria and Switzerland) consensus statement concerning the diagnostic and treatment of myalgic encephalomyelitis/chronic fatigue syndrome].

Hoffmann K, Hainzl A, Stingl M, Kurz K, Biesenbach B, Bammer C Wien Klin Wochenschr. 2024; 136(Suppl 5):103-123.

PMID: 38743348 PMC: 11093804. DOI: 10.1007/s00508-024-02372-y.

References

Nacul L, Mudie K, Kingdon C, Clark T, Lacerda E . Hand Grip Strength as a Clinical Biomarker for ME/CFS and Disease Severity. Front Neurol. 2018; 9:992. PMC: 6277492. DOI: 10.3389/fneur.2018.00992. View

Kim L, Kedor C, Buttgereit F, Heidecke H, Schaumburg D, Scheibenbogen C . Characterizing Sjögren-Associated Fatigue: A Distinct Phenotype from ME/CFS. J Clin Med. 2023; 12(15). PMC: 10419548. DOI: 10.3390/jcm12154994. View

Saunders C, Sperling S, Bendstrup E . A new paradigm is needed to explain long COVID. Lancet Respir Med. 2023; 11(2):e12-e13. DOI: 10.1016/S2213-2600(22)00501-X. View

White P, Goldsmith K, Johnson A, Potts L, Walwyn R, DeCesare J . Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet. 2011; 377(9768):823-36. PMC: 3065633. DOI: 10.1016/S0140-6736(11)60096-2. View

Vink M, Vink-Niese A . The Updated NICE Guidance Exposed the Serious Flaws in CBT and Graded Exercise Therapy Trials for ME/CFS. Healthcare (Basel). 2022; 10(5). PMC: 9141828. DOI: 10.3390/healthcare10050898. View

Chu L, Valencia I, Garvert D, Montoya J . Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey. PLoS One. 2018; 13(6):e0197811. PMC: 5983853. DOI: 10.1371/journal.pone.0197811. View

Campen C, Rowe P, Visser F . Reductions in Cerebral Blood Flow Can Be Provoked by Sitting in Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Healthcare (Basel). 2020; 8(4). PMC: 7712289. DOI: 10.3390/healthcare8040394. View

Fluge O, Mella O, Bruland O, Risa K, Dyrstad S, Alme K . Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight. 2016; 1(21):e89376. PMC: 5161229. DOI: 10.1172/jci.insight.89376. View

Sunnquist M, Jason L . A reexamination of the cognitive behavioral model of chronic fatigue syndrome. J Clin Psychol. 2018; 74(7):1234-1245. PMC: 6002889. DOI: 10.1002/jclp.22593. View

10.

Stevens S, Snell C, Stevens J, Keller B, Vanness J . Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front Pediatr. 2018; 6:242. PMC: 6131594. DOI: 10.3389/fped.2018.00242. View

11.

van Campen C, Verheugt F, Rowe P, Visser F . Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography. Clin Neurophysiol Pract. 2020; 5:50-58. PMC: 7044650. DOI: 10.1016/j.cnp.2020.01.003. View

12.

van Campen C, Rowe P, Visser F . Worsening Symptoms Is Associated with Larger Cerebral Blood Flow Abnormalities during Tilt-Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Medicina (Kaunas). 2023; 59(12). PMC: 10744908. DOI: 10.3390/medicina59122153. View

13.

Cornish F, Stelson E . Concerns regarding a suggested long COVID paradigm. Lancet Respir Med. 2023; 11(4):e35. DOI: 10.1016/S2213-2600(23)00095-4. View

14.

Brenu E, Van Driel M, Staines D, Ashton K, Ramos S, Keane J . Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J Transl Med. 2011; 9:81. PMC: 3120691. DOI: 10.1186/1479-5876-9-81. View

15.

Light N, Fernbach P, Rabb N, Geana M, Sloman S . Knowledge overconfidence is associated with anti-consensus views on controversial scientific issues. Sci Adv. 2022; 8(29):eabo0038. PMC: 9299547. DOI: 10.1126/sciadv.abo0038. View

16.

Nepotchatykh E, Elremaly W, Caraus I, Godbout C, Leveau C, Chalder L . Profile of circulating microRNAs in myalgic encephalomyelitis and their relation to symptom severity, and disease pathophysiology. Sci Rep. 2020; 10(1):19620. PMC: 7665057. DOI: 10.1038/s41598-020-76438-y. View

17.

Light A, Bateman L, Jo D, Hughen R, VanHaitsma T, White A . Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome. J Intern Med. 2011; 271(1):64-81. PMC: 3175315. DOI: 10.1111/j.1365-2796.2011.02405.x. View

18.

Moore G, Keller B, Stevens J, Mao X, Stevens S, Chia J . Recovery from Exercise in Persons with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Medicina (Kaunas). 2023; 59(3). PMC: 10059925. DOI: 10.3390/medicina59030571. View

19.

Freitag H, Szklarski M, Lorenz S, Sotzny F, Bauer S, Philippe A . Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J Clin Med. 2021; 10(16). PMC: 8397061. DOI: 10.3390/jcm10163675. View

20.

Hawk C, Jason L, Torres-Harding S . Differential diagnosis of chronic fatigue syndrome and major depressive disorder. Int J Behav Med. 2006; 13(3):244-51. DOI: 10.1207/s15327558ijbm1303_8. View